Erasca
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Erasca and other ETFs, options, and stocks.About ERAS
Erasca, Inc. is a clinical stage precision oncology company. It focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers.
CEOJonathan E. Lim
CEOJonathan E. Lim
Employees103
Employees103
HeadquartersSan Diego, California
HeadquartersSan Diego, California
Founded2018
Founded2018
Employees103
Employees103
ERAS Key Statistics
Market cap4.79B
Market cap4.79B
Price-Earnings ratio-34.32
Price-Earnings ratio-34.32
Dividend yield—
Dividend yield—
Average volume4.12M
Average volume4.12M
High today$15.97
High today$15.97
Low today$14.97
Low today$14.97
Open price$15.54
Open price$15.54
Volume5.05M
Volume5.05M
52 Week high$16.00
52 Week high$16.00
52 Week low$1.01
52 Week low$1.01
Stock Snapshot
With a market cap of 4.79B, Erasca(ERAS) trades at $15.60. The stock has a price-to-earnings ratio of -34.32.
During the trading session on 2026-03-08, Erasca(ERAS) shares reached a daily high of $15.97 and a low of $14.97. At a current price of $15.60, the stock is +4.2% higher than the low and still -2.3% under the high.
Trading activity shows a volume of 5.05M, compared to an average daily volume of 4.12M.
The stock's 52-week range extends from a low of $1.01 to a high of $16.00.
The stock's 52-week range extends from a low of $1.01 to a high of $16.00.
Analyst ratings
82%
of 11 ratingsBuy
81.8%
Hold
9.1%
Sell
9.1%
People also own
Based on the portfolios of people who own ERAS. This list is generated using Robinhood data, and it’s not a recommendation.